{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT04130100",
      "OrgStudyIdInfo": {
        "OrgStudyId": "KT005SH002"
      },
      "Organization": {
        "OrgFullName": "CAR-T (Shanghai) Biotechnology Co., Ltd.",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "Clinical Study of Pulp Mesenchymal Stem Cells in the Treatment of Primary Mild to Moderate Knee Osteoarthritis",
      "OfficialTitle": "To Evaluate the Safety and Efficacy of Dental Pulp Mesenchymal Stem Cells in the Treatment of Primary Mild to Moderate Knee Osteoarthritis Using Sodium Hyaluronate as a Parallel Control."
    },
    "StatusModule": {
      "StatusVerifiedDate": "October 2019",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "April 4, 2019",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "September 30, 2021",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "December 30, 2021",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "October 11, 2019",
      "StudyFirstSubmitQCDate": "October 15, 2019",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "October 17, 2019",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "October 15, 2019",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "October 17, 2019",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "CAR-T (Shanghai) Biotechnology Co., Ltd.",
        "LeadSponsorClass": "INDUSTRY"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No",
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "To evaluate the clinical efficacy and safety of dental pulp mesenchymal stem cells in the treatment of primary mild to moderate knee osteoarthritis through a comparative study with sodium hyaluronate.\n\n20 participants will receive low dose of dental pulp mesenchymal stem cells, 20 participants will receive high dose and another 20 participants will receive sodium hyaluronate",
      "DetailedDescription": "60 participants will receive to evaluate the clinical efficacy and safety of dental pulp mesenchymal stem cells in the treatment of primary mild to moderate knee osteoarthritis through a comparative study with sodium hyaluronate and verify the basis of dental pulp mesenchymal stem cells in the treatment of primary knee osteoarthritis, and to explore a more effective and safe clinical treatment of knee osteoarthritis."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Knee Osteoarthritis"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Early Phase 1"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignInterventionModelDescription": "low dose of dental pulp mesenchymal stem cells high dose of dental pulp mesenchymal stem cells Sodium hyaluronate",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "60",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Low Dose of Mesenchymal stem cell",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Patients receiving intraarticular injection of low dose of mesenchymal stem cells.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Low Dose of Mesenchymal stem cell"
              ]
            }
          },
          {
            "ArmGroupLabel": "High Dose of Mesenchymal stem cell",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Patients receiving intraarticular injection of high dose of mesenchymal stem cells.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: High Dose of Mesenchymal stem cell"
              ]
            }
          },
          {
            "ArmGroupLabel": "Sodium Hyaluronate",
            "ArmGroupType": "Active Comparator",
            "ArmGroupDescription": "Patients receiving intraarticular injection of Sodium Hyaluronate",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: Sodium Hyaluronate"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Low Dose of Mesenchymal stem cell",
            "InterventionDescription": "Mesenchymal stem cell injection",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Low Dose of Mesenchymal stem cell"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "1"
              ]
            }
          },
          {
            "InterventionType": "Biological",
            "InterventionName": "High Dose of Mesenchymal stem cell",
            "InterventionDescription": "Mesenchymal stem cell injection",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "High Dose of Mesenchymal stem cell"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "2"
              ]
            }
          },
          {
            "InterventionType": "Drug",
            "InterventionName": "Sodium Hyaluronate",
            "InterventionDescription": "Sodium Hyaluronate injection",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Sodium Hyaluronate"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "3"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Kellgren and Lawrence's rating",
            "PrimaryOutcomeDescription": "X-ray imaging was used to evaluate the degree of improvement in knee joint structure",
            "PrimaryOutcomeTimeFrame": "12 month"
          },
          {
            "PrimaryOutcomeMeasure": "WOMAC score",
            "PrimaryOutcomeDescription": "WOMAC score decreased",
            "PrimaryOutcomeTimeFrame": "12 month"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Volume of femoral surface of knee joint on MRI",
            "SecondaryOutcomeDescription": "Changes of volume of lateral femoral condylar, medial femoral condylar, lateral tibial condylar, medial tibial condylar and posterior patellar articular surfaces on MRI",
            "SecondaryOutcomeTimeFrame": "12 month"
          },
          {
            "SecondaryOutcomeMeasure": "relaxation time of femoral surface of knee joint on MRI",
            "SecondaryOutcomeDescription": "Changes of relaxation time (T1 condylar, T2 condylar, T2*) of lateral femoral condylar, medial femoral condylar, lateral tibial condylar, medial tibial condylar and posterior patellar articular surfaces on MRI",
            "SecondaryOutcomeTimeFrame": "12 month"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nComplying with the diagnostic criteria for primary knee osteoarthritis revised by the American Rheumatological Association (1995), age 40-70 years, gender-free.\nFor patients with mild to moderate knee arthritis, the WOMAC score of knee joint was less than 120.\nX-ray Kellgren-Lawrence was used to evaluate the grade I, II and III of osteoarthritis.\nFertility patients should take effective contraceptive measures until the end of follow-up. Fertility women should exclude the possibility of early pregnancy, that is, HCG negative test in early pregnancy.\nVoluntary participation in this clinical study, can cooperate with doctors to carry out research, stop all medical measures for knee arthritis for more than 2 weeks, and sign the informed consent of patients.\n\nExclusion Criteria:\n\n(1) Those with other diseases that may affect the knee joint, such as rheumatoid arthritis, ankylosing spondylitis, rheumatoid arthritis, gout and other rheumatic diseases, bone tumors, osteoporosis, bone tuberculosis or obvious history of acute trauma, resulting in meniscus injury, ligament rupture and vascular nerve injury; those with previous history of femur, tibial plateau, tibia and fibula fracture. The patients with gonarthritis, the patients with knee joint and surrounding skin infection were not cured.\n\n2) Patients who have undergone surgery and other factors affecting the efficacy of the treatment. Patients with severe deformities or even deformities of the knee joint, who need surgical treatment. Patients who have received knee joint irrigation or arthroscopic examination within one year.\n\n3) Patients with systemic cancer tendency or cancer and patients with systemic infection in active stage.\n\n4) Patients with severe heart, lung, liver, kidney, blood system, endocrine system and immune deficiency, or abnormal laboratory biochemical indicators, namely: hemoglobin (Hb) < 9 g/dL, white blood cell (WBC) > 15 x 109/L, platelet (Pt) < 100 x 109/L, glutamic oxalate transaminase (AST) and alanine aminotransferase (ALT) > 1.5 times normal upper limit; serum creatinine > 1.5 times normal upper limit.\n\n5) Physical history or clinical manifestations with bleeding tendency, including patients currently using anticoagulants.\n\n6) Patients with uncontrollable epileptic seizures, psychosis or Alzheimer's disease who are unable to complete the scale.\n\n7) Pregnant or lactating women, legal disabled patients (blind, deaf, dumb, mentally retarded, physically disabled), drug addiction and other adverse drug addiction.\n\n8) Patients with contraindications or allergies were examined and treated in this study.\n\n9) Those who have participated in other clinical studies within one month.\n\n10) Researchers consider it inappropriate for patients to participate in this clinical study.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "40 Years",
      "MaximumAge": "70 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Dongbao Zhao, Doctor",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "+86-18317079530",
            "CentralContactEMail": "aolin_521@163.com"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Dongbao Zhao, Doctor",
            "OverallOfficialAffiliation": "Changhai Hospital",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Changhai hospital",
            "LocationStatus": "Recruiting",
            "LocationCity": "Shanghai",
            "LocationCountry": "China",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Guangrong Song, Doctor",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "+86-13918384480",
                  "LocationContactEMail": "songguangrong@cart-sh.com"
                }
              ]
            }
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "No"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000010003",
            "ConditionMeshTerm": "Osteoarthritis"
          },
          {
            "ConditionMeshId": "D000020370",
            "ConditionMeshTerm": "Osteoarthritis, Knee"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000001168",
            "ConditionAncestorTerm": "Arthritis"
          },
          {
            "ConditionAncestorId": "D000007592",
            "ConditionAncestorTerm": "Joint Diseases"
          },
          {
            "ConditionAncestorId": "D000009140",
            "ConditionAncestorTerm": "Musculoskeletal Diseases"
          },
          {
            "ConditionAncestorId": "D000012216",
            "ConditionAncestorTerm": "Rheumatic Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M12078",
            "ConditionBrowseLeafName": "Osteoarthritis",
            "ConditionBrowseLeafAsFound": "Osteoarthritis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M21321",
            "ConditionBrowseLeafName": "Osteoarthritis, Knee",
            "ConditionBrowseLeafAsFound": "Knee Osteoarthritis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M3628",
            "ConditionBrowseLeafName": "Arthritis",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9773",
            "ConditionBrowseLeafName": "Joint Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11249",
            "ConditionBrowseLeafName": "Musculoskeletal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14197",
            "ConditionBrowseLeafName": "Rheumatic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5475",
            "ConditionBrowseLeafName": "Collagen Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC05",
            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC17",
            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionMeshList": {
        "InterventionMesh": [
          {
            "InterventionMeshId": "D000006820",
            "InterventionMeshTerm": "Hyaluronic Acid"
          }
        ]
      },
      "InterventionAncestorList": {
        "InterventionAncestor": [
          {
            "InterventionAncestorId": "D000000276",
            "InterventionAncestorTerm": "Adjuvants, Immunologic"
          },
          {
            "InterventionAncestorId": "D000007155",
            "InterventionAncestorTerm": "Immunologic Factors"
          },
          {
            "InterventionAncestorId": "D000045505",
            "InterventionAncestorTerm": "Physiological Effects of Drugs"
          },
          {
            "InterventionAncestorId": "D000055675",
            "InterventionAncestorTerm": "Viscosupplements"
          },
          {
            "InterventionAncestorId": "D000020011",
            "InterventionAncestorTerm": "Protective Agents"
          }
        ]
      },
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M9030",
            "InterventionBrowseLeafName": "Hyaluronic Acid",
            "InterventionBrowseLeafAsFound": "Induction of anesthesia",
            "InterventionBrowseLeafRelevance": "high"
          },
          {
            "InterventionBrowseLeafId": "M2780",
            "InterventionBrowseLeafName": "Adjuvants, Immunologic",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M9353",
            "InterventionBrowseLeafName": "Immunologic Factors",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M27448",
            "InterventionBrowseLeafName": "Viscosupplements",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M21022",
            "InterventionBrowseLeafName": "Protective Agents",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}